Separation Systems For Commercial Biotechnology Market Trends

Statistics for the 2023 & 2024 Separation Systems For Commercial Biotechnology market trends, created by Mordor Intelligence™ Industry Reports. Separation Systems For Commercial Biotechnology trend report includes a market forecast to 2029 and historical overview. Get a sample of this industry trends analysis as a free report PDF download.

Market Trends of Separation Systems For Commercial Biotechnology Industry

Biopharmaceutical Segment is Anticipated to Witness a Growth Over the Forecast Period

  • In the biopharmaceutical field, the separation stage is applied to remove unwanted by-products from API manufacturing, and the most used technologies are chromatography, nanofiltration, ultrafiltration, sublimation, de-sublimation, distillation, and crystallization. The biopharmaceutical segment is expected to witness significant market growth in the market owing to the increase in demand for personalized medicines and cell-based therapies coupled with advancements in the biopharmaceutical industry. 
  • For instance, in November 2022, Alfa Laval launched a new multipurpose membrane filtration system that can be seamlessly connected to both up and downstream operations. It increases flexibility across a range of process applications. This includes the purification of proteins, sugar, and starch, the concentration of peptides and amino acid streams, and the recovery of water from condensates.
  • Moreover, according to the article published in September 2022 in London, The identification of a molecule with therapeutic potential is the initial step in the development of a medicine, after which molecules such as drug candidates are examined for metabolism and pharmacokinetics. Because of their great sensitivity and selectivity, these chemicals are routinely tested using combination techniques such as liquid chromatography-mass spectrometry (LC-MS) or LC-MS/MS. 
  • Furthermore, an increase in biopharmaceutical plants across the globe is likely to increase the utilization of separation systems. For instance, in May 2022, INCOG BioPharma Services, an Indiana-based contract development and manufacturing organization (CDMO) specializing in sterile injectables, opened a biomanufacturing facility in Indiana.
  • Hence, due to the increase in product launches and advancements in cell separation in biotechnology, the biopharmaceutical segment is expected to witness significant growth over the forecast period.
Separation Systems For Commercial Biotechnology Market: Estimated Research Funding for Biotechnology, (USD Million), By Year, Global, 2021-2022

North America Anticipated to Hold a Significant Share in the Market Over the Forecast Period

  • North America is expected to hold a significant market share throughout the forecast period due to factors such as the presence of key players, an increase in research activities utilizing the separation systems, and established healthcare infrastructure. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase market growth.
  • For instance, as per the NIH 2022 update, the estimated research funding for biotechnology was USD 8,142 million in 2022. Hence, such high investments by the government are likely to drive market growth.
  • Similarly, as per a 2021 update by the University of North Dakota, the UND Center of Biomedical Research Excellence (CoBRE) in Host-Pathogen interactions (HPI) has stated that the National Institutes of Health (NIH) funding will continue its funding throughout Phase 2 of the project.
  • The USD 10.7 million amount renewal is granted for obtaining a better understanding of the host responses to viral, bacterial, and parasitic infections that cause acute and chronic inflammatory disorders. The Center will also enhance the innovative research capabilities of the School of Medicine & Health Sciences (SMHS) and UND by supporting three existing Phase 1 Core facilities, including flow cytometry.
  • Various governmental research organizations use the HPLC technique in the analysis of specific components in a drug mixture or similar components. An article by the United States Environmental Protection Agency (EPA) updated in May 2021 on the High-Performance Environmental Sampling and Analytical Methods (ESAM) Program focused on the Determination of Carbonyl Compounds by using High-Performance Liquid Chromatography (HPLC). Such application of HPLC techniques as standard protocols for sample analysis is adding to the growth of the market in the North American region.
  • Hence, due to the increase in advancements in separation systems and the rise in research funding, North America is expected to hold a significant market share over the forecast period.
Separation Systems for Commercial Biotechnology Market - Growth Rate by Region

Separation Systems for Commercial Biotechnology Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)